GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (STU:1RC) » Definitions » Gross Profit

Creo Medical Group (STU:1RC) Gross Profit : €17.80 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group Gross Profit?

Creo Medical Group's gross profit for the six months ended in Dec. 2023 was €9.05 Mil. Creo Medical Group's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was €17.80 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Creo Medical Group's gross profit for the six months ended in Dec. 2023 was €9.05 Mil. Creo Medical Group's Revenue for the six months ended in Dec. 2023 was €17.53 Mil. Therefore, Creo Medical Group's Gross Margin % for the quarter that ended in Dec. 2023 was 51.66%.

Creo Medical Group had a gross margin of 51.66% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 9 years, the highest Gross Margin % of Creo Medical Group was 49.68%. The lowest was 38.46%. And the median was 46.04%.


Creo Medical Group Gross Profit Historical Data

The historical data trend for Creo Medical Group's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group Gross Profit Chart

Creo Medical Group Annual Data
Trend Feb14 Feb15 Feb16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only 0.01 4.46 13.63 15.18 17.76

Creo Medical Group Semi-Annual Data
Feb14 Feb15 Feb16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.42 7.57 7.70 8.74 9.05

Competitive Comparison of Creo Medical Group's Gross Profit

For the Medical Devices subindustry, Creo Medical Group's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creo Medical Group's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's Gross Profit distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's Gross Profit falls into.



Creo Medical Group Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Creo Medical Group's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=35.751 - 17.991
=17.76

Creo Medical Group's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=17.527 - 8.473
=9.05

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €17.80 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Creo Medical Group's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=9.05 / 17.527
=51.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Creo Medical Group  (STU:1RC) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Creo Medical Group had a gross margin of 51.66% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Creo Medical Group Gross Profit Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Creo Medical Group (STU:1RC) Business Description

Traded in Other Exchanges
Address
Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (STU:1RC) Headlines

No Headlines